Nehodí se? Vůbec nevadí! U nás můžete do 30 dní vrátit
S dárkovým poukazem nešlápnete vedle. Obdarovaný si za dárkový poukaz může vybrat cokoliv z naší nabídky.
30 dní na vrácení zboží
Cytomegalovirus hyperimmunoglobulin (CMVIg) containing drugs are routinely administered in solid organ transplantation for prophylaxis against CMV disease. Yet little is known about their influence on transplant relevant immune functions.§The aim of this work was to evaluate the effect of CMVIg on cellular immunity in vitro and to define their role in tolerance inducing mechanisms. Our results show that CMVIg induce immunological features on leukocytes in vitro, which are known to be related to tolerance induction in vivo. These observations extend the current concept of CMVIg as passive CMV prophylaxis to a therapeutic drug compound capable to reduce allogeneic immune response.